Vialto Partners, a provider of tax and immigration services, has agreed to restructure its debt a little more than two years ...

To help find and source new investments, the private investment firm adds the CEO Anixter had at the time it merged with ...

Resideo Technologies (REZI) has disclosed a new risk, in the Share Price & Shareholder Rights category. The CD&R Stockholder, holding approximately 11% of Resideo Technologies’ total voting power as ...

Clayton, Dubilier & Rice has named Bill Galvin as an operating advisor. Galvin is the former president and CEO of Anixter International. In his new role. Galvin will play an active role in helping the ...

Sanofi (EPA:SASY)(NASDAQ:SNY) has entered into exclusive negotiations with private equity firm Clayton, Dubilier & Rice to ...

The renewed negotiations come after CD&R agreed to pledges around local jobs, investments and production, Bloomberg reported earlier. Sanofi encountered a backlash in France when it chose the US ...

PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton ...

The deal would allow Sanofi to focus on its more lucrative, but riskier, innovative drugs and vaccines, and CD&R to take a 50% controlling stake in a business that is home to brands such as ...

CD&R is also considering the French government’s request to keep the consumer health unit’s headquarters in France, said the people, who asked not to be identified as the information is private.

Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcareSanofi and CD&R enter exclusive negotiations to transfer a 50% ...

A group including CD&R and existing lenders, including HPS Investment Partners, agreed to a deal that will inject $225 ...

PARIS (Reuters) -Sanofi said on Monday it had entered exclusive talks for the sale of a 50% controlling stake in its consumer ...